CA
IDYA icon

Clearstead Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Clearstead Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45K Buy
+39
New +$1.19K ﹤0.01% 2589
2025
Q2 		– Sell
-528
Closed -$8.65K – 2804
2025
Q1 		$8.65K Hold
528
– – ﹤0.01% 1641
2024
Q4 		$13.6K Hold
528
– – ﹤0.01% 1501
2024
Q3 		$16.7K Buy
528
+111
+27% +$4.21K ﹤0.01% 1475
2024
Q2 		$14.6K Buy
+417
New +$16.5K ﹤0.01% 1454
2023
Q1 		– Sell
-1,251
Closed -$22.7K – 1397
2022
Q4 		$22.7K Hold
1,251
– – ﹤0.01% 777
2022
Q3 		$19K Hold
1,251
– – ﹤0.01% 780
2022
Q2 		$17K Hold
1,251
– – ﹤0.01% 834
2022
Q1 		$14K Hold
1,251
– – ﹤0.01% 928
2021
Q4 		$30K Sell
1,251
-625
-33% -$14.5K ﹤0.01% 734
2021
Q3 		$48K Hold
1,876
– – ﹤0.01% 617
2021
Q2 		$39K Hold
1,876
– – ﹤0.01% 596
2021
Q1 		$44K Buy
+1,876
New +$36.2K ﹤0.01% 561

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Clearstead Advisors's IDYA Position: Q2 2026 in Review

Clearstead Advisors opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 39 shares worth $1.45K. The stake represents ﹤0.01% of the portfolio and ranks #2589 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in IDYA as recently as Q1 2025.

Clearstead Advisors first reported a position in IDYA in Q1 2021 and has held it in 13 quarters since. The position peaked at $48K in Q3 2021. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Clearstead Advisors held 39 shares of IDEAYA Biosciences worth $1.45K as of Q2 2026.
  • IDEAYA Biosciences was a new Clearstead Advisors position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2589 holding.
  • Clearstead Advisors first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 13 quarters since.
  • Clearstead Advisors's IDEAYA Biosciences position peaked at $48K in Q3 2021.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.